ArsenalBio Funding & Investors
ArsenalBio’s mission is to develop efficacious and safe cellular therapies for patients with chronic diseases, initially cancer.
arsenalbio.comTotal Amount Raised: $630,806,656
ArsenalBio Funding Rounds
Series C
$325,000,000
Series C Investors
SoftBank Vision FundNVenturesBristol-Myers SquibbT. Rowe PriceRock Springs CapitalArch Venture PartnersParker Institute for Cancer ImmunotherapyWestlake Village BioPartnersByers CapitalKleiner PerkinsHitachi VenturesRegeneron VenturesMilky Way Investments GroupLuma GroupSeries B
$220,806,682
Series B Investors
SoftBank Vision FundByers CapitalWaycross VenturesGreen Sands EquityHitachi VenturesUCSFKleiner PerkinsWestlake Village BioPartnersEmerson CollectiveBristol-Myers SquibbParker Institute for Cancer ImmunotherapyEuclidean CapitalSixth StreetTriatomic CapitalSeries A
$85,000,000
Series A Investors
Ucsf Foundation Investment CompanyKleiner PerkinsUniversity of CaliforniaParker Institute for Cancer ImmunotherapyEuclidean CapitalWestlake Village BioPartnersOUP Management
Funding info provided by Diffbot.